Bayer: A history
By GMWatch,
GMWatch
| 04. 19. 2022
How a chemical and pharmaceutical giant with an appalling record of corporate crimes became a key player in the development, commercialization and sale of GM crops
Bayer AG is a chemical and pharmaceutical giant founded in Barmen, Germany in 1863 by Friedrich Bayer and his partner, Johann Friedrich Weskott. Today it has its headquarters in Leverkusen, North Rhine-Westphalia, Germany.
The merger between Bayer and Monsanto in June of 2018 led many commentators to say the German firm had sullied its reputation by taking over a company consistently shown in polls to be among the most hated in America. But Bayer's own corporate record also bears little scrutiny.
A look at the company's history may, in fact, help to explain how Bayer thought it could take over a firm up to its neck in controversies and court cases and just rebrand Monsanto's products as its own and rake in the profits. After all, as we shall see, for more than a century Bayer has been walking away from corporate crimes from which it has successfully profited.
The product that Bayer is perhaps most famous for is aspirin, which it trademarked in 1899. Bayer's official history has credited Felix Hoffmann with its invention in 1897. But according to Arthur Eichengrün, another chemist employed by Bayer at the time, he...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...